Injection Pen Market is expected to expand at a CAGR of 6.0% Forecast Period
During the projected period of 2022–2030, the global
injection pen market is expected to develop at a compound
annual growth rate (CAGR) of 6.0%.
Insulin pens, sometimes referred to as injection pens,
are advanced prefilled syringes that have been carefully created for
self-administration of drug delivery in a variety of therapies and chronic
illnesses. Small doses of hormones or medications are injected into patients'
bodies using these pens to treat specific disorders. These pens efficiently
replace conventional injection methods for treating a range of medical diseases
since they are portable, more precise, straightforward, user-friendly, and
handy in their delivery.
Download
Request for Sample@ https://www.xresearch.biz/request-sample-pages/injection-pen-market
Growth
Drivers:
The primary factors propelling this market's expansion
are the rising prevalence of conditions like diabetes and arthritis among
people worldwide, the surge in demand for safer and more advanced drug delivery
devices, the rising geriatric population, the technological advancements in
injection pens, the rising number of regulatory approvals, the favourable
reimbursement environment in developed economies, and the rising use of home
healthcare.
Additionally, as the number of people using injection
pens to treat insulin-related issues increases around the world, the
manufacturers of injection pen are seen to be placing major emphasis on
improving the design characteristics of the injection pens, the ease of
injection, the use of the insulin-dose setting dial, the simplicity of
cartilage replacement, and the prominence of audio clicks. The growth of the
worldwide injection market is predicted to be greatly aided by this aspect
throughout the projected period.
The studies are now focusing on the use of these pens in
significant diseases that require periodic dose injections, such as cancer,
multiple sclerosis, hepatitis C, etc. This is due to the injection pens'
consistent success in the management of numerous chronic as well as acute
disorders. During the forecast period, this aspect is anticipated to generate a
lot of potential chances for the worldwide injection
pen market.
Nevertheless, factors like a lack of knowledge about the
use of injection pens, the high cost of injection pens, and the rising
preference for alternative drug delivery methods because of a fear of syringes
are anticipated to significantly restrain the growth of the global injection
pen market during the forecast period.
Injection Pen Market
Segmentation:
By Type:
· Disposable
Injection Pens
· Reusable
Injection Pens
By End User:
· Home
Care
· Hospital
& Clinics
· Others
By Therapy:
· Diabetes
o Insulin
o GLP-1
· Growth
Hormone Therapy
· Fertility
· Osteoporosis
· Other
Therapies
By Dosage:
· Fixed
· Variable
By Region:
· North
America
· Europe
· Asia
Pacific
· Latin
America
· Middle
East and Africa
Key Companies in
Injection Pen Market:
· AstraZeneca
· Novartis
· Roche
Holding AG
· Medtronic
· Sanofi
· Becton
Dickinson and Company
· Eli
Lilly Company
· Novo
Nordisk
· F.
Hoffman-La Roche
· Mylan
N.V
· Sandoz
Inc
· Merck
Group
· Haselmeier
· Gerresheimer
AG
· Ypsomed
· Pfizer
Inc.
· Owen
Mumford Ltd
· GlaxoSmithKline
plc
· Other
Players
Read
More Information: https://www.xresearch.biz/shop/injection-pen-market
About Us:-
xResearch is a market
research and consulting organization that uses unique data, expert analysis,
and new technologies to create trusted intelligence on industries. Our research
is focused on delivering an informed and impartial view on essential market
data of industry, and it is primarily driven by an in-depth study covering the
following parameters: Market Sizing and Forecasting, Market Segmentation, Competitive Analysis, Strategic Assessment and Business Modelling.
Contact:
Company Name: xResearch
Contact Person: James Lin
Email: sales@xresearch.biz
Phone: +1 718-618-4545
Comments
Post a Comment